Application Nr Approved Date Route Status External Links
ANDA213038 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Efavirenz, Lamivudine And Tenofovir Disoproxil Fumarate Tablets Are Indicated As A Complete Regimen For The Treatment Of Human Immunodeficiency Virus Type 1 (Hiv-1) Infection In Adult And Pediatric Patients Weighing At Least 35 Kg. Efavirenz, Lamivudine And Tenofovir Disoproxil Fumarate Tablets Are Three-Drug Combination Of Efavirenz (Efv), A Non-Nucleoside Reverse Transcriptase Inhibitor, And Lamivudine (3tc) And Tenofovir Disoproxil Fumarate (Tdf), Both Nucleo(T)side Reverse Transcriptase Inhibitors And Are Indicated As A Complete Regimen For The Treatment Of Human Immunodeficiency Virus Type 1 (Hiv-1) Infection In Adult And Pediatric Patients Weighing At Least 35 Kg. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 3 Total)

Comments